Premium
Healthcare private equity firm InvAscent is set to add more money to its India-focused third fund before hitting the final close, a person in the know told VCCircle. India Life Sciences Fund III has raised $224 million (Rs 1,584 crore) from 25 investors so far, show regulatory filings. The final close is ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
